It is trading at $0.90 which is significantly above the 50 day moving average which is $0.76 and which is well above the 200 day moving average of $0.79. The 50 day moving average went up $0.15 or +19.3275% and the 200 day average went up by +15.0893%. 147K shares changed hands in the last trading session. Volume was down 35.53% under the stocks average daily volume.
Short traders are more bullish on the company recently as shown by the decrease in short interest. The stock experienced a fall in short interest between September 29, 2017 and October 13, 2017 of -4.53%. Short interest decreased 46,541 over that period. With short interest at 980,569 and short average daily volume at 286,078, days to cover is 3.0 and the short interest percentage is 0.02% as of October 13.
Additionally, here are a few investment firms who have increased or decreased their stake in (SNMX). As of quarter end Davenport & Co LLC had sold a total of 4,000 shares trimming its holdings by 4.3%. The value of the investment in SNMX decreased from $77,273,000 to $53,995,000 a change of 30.1% since the last quarter. As of the end of the quarter Cutler Group LP had disposed of 1,225 shares trimming its position 92.5%. The value in dollars went from $1,000 to $0 a change of $1,000 for the reporting period.
As of quarter end Ingalls & Snyder LLC had sold 66,300 shares trimming its stake by 85.8%. The value of the investment in Senomyx, Inc. decreased from $64,000 to $7,000 decreasing 89.1% quarter over quarter. Raymond James Financial Services Advisors, Inc. grew its ownership by buying 5,000 shares an increase of 20.2% in the quarter. Raymond James Financial Services Advisors, Inc. controls 29,750 shares worth $18,000. The total value of its holdings decreased 14.3%.
In the latest earnings report the EPS was $-0.27 and is projected to be $-0.27 for the current year with 47,514,000 shares presently outstanding. Analysts expect next quarter’s EPS will be $-0.06 with next year’s EPS projected to be $-0.21.
Senomyx, Inc., launched on September 16, 1998, is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. The Company is involved in the discovery, development and/or commercialization of flavor ingredients through its approximately five programs focused on sweet, savory, bitter, cooling and salt taste areas. The Business’s taste receptor-based assays are used in its screening systems and for screening its compound libraries and identifying flavor ingredients..